Castle Biosciences, Inc. (CSTL)
24.65
+0.28
(+1.15%)
USD |
NASDAQ |
Apr 15, 16:00
24.65
0.00 (0.00%)
After-Hours: 20:00
Castle Biosciences Research and Development Expense (Annual) : 51.50M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Delcath Systems, Inc. | 29.25M |
| Assertio Holdings, Inc. | 1.69M |
| CytoSorbents Corp. | 5.085M |
| Odyssey Health, Inc. | 0.00 |
| Harmony Biosciences Holdings, Inc. | 189.59M |